Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells - PubMed (original) (raw)
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
A Calender et al. Proc Natl Acad Sci U S A. 1987 Nov.
Abstract
A set of B-cell activation markers, including the EBV/C3d receptor [complement receptor type 2 (CR2) (CD21)], the 45-kDa lymphoblastoid cell-associated (Blast-2) antigen (CD23), and the B-cell restricted activation (Bac-1) antigen (which was recently identified as a potential B-cell growth factor receptor) can be turned on by infecting lymphoma cells that are genome negative for Epstein-Barr virus (EBV) with the B95-8 immortalizing strain of the virus. The nonimmortalizing EBV variant, strain P3HR-1, which possesses a deletion within the BamHI WYH region of the genome containing the coding sequence for the EBV-determined nuclear antigen 2, does not induce expression of these markers. Other lymphoblastoid cell-associated antigen markers can be activated by infection with either immortalizing or nonimmortalizing viruses. These results suggest that the immortalizing potential of EBV is correlated with its ability to induce expression of B-cell activation markers, which are suspected to play a major role in the physiological pathway leading to lymphoid cell proliferation. The viral genomic region deleted in the nonimmortalizing strain of EBV seems to be required for activation of some of these markers. Human lymphoma cell lines, such as those used in this study, can thus help identify the specific EBV genes involved in lymphoid B-cell proliferation and the mechanism of action of these genes.
Similar articles
- Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM. Cordier M, et al. J Virol. 1990 Mar;64(3):1002-13. doi: 10.1128/JVI.64.3.1002-1013.1990. J Virol. 1990. PMID: 2154588 Free PMC article. - Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).
Calender A, Cordier M, Billaud M, Lenoir GM. Calender A, et al. Int J Cancer. 1990 Oct 15;46(4):658-63. doi: 10.1002/ijc.2910460418. Int J Cancer. 1990. PMID: 1698730 - Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
Cohen JH, Fischer E, Kazatchkine MD, Lenoir GM, Lefevre-Delvincourt C, Revillard JP. Cohen JH, et al. Scand J Immunol. 1987 Jun;25(6):587-98. doi: 10.1111/j.1365-3083.1987.tb01085.x. Scand J Immunol. 1987. PMID: 3037684 - [Epstein-Barr virus associated lymphocyte proliferation].
Stein H, Hummel M, Anagnostopoulos I, Korbjuhn P, Niedobitek G, Dallenbach F, Herbst H. Stein H, et al. Verh Dtsch Ges Pathol. 1992;76:79-95. Verh Dtsch Ges Pathol. 1992. PMID: 1283280 Review. German. - Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E. Tatsumi E. Hum Cell. 1992 Mar;5(1):79-86. Hum Cell. 1992. PMID: 1329932 Review.
Cited by
- LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
Zhang J, Sommermann T, Li X, Gieselmann L, de la Rosa K, Stecklum M, Klein F, Kocks C, Rajewsky K. Zhang J, et al. Front Immunol. 2023 Dec 19;14:1331730. doi: 10.3389/fimmu.2023.1331730. eCollection 2023. Front Immunol. 2023. PMID: 38169736 Free PMC article. - Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection.
SoRelle ED, Dai J, Reinoso-Vizcaino NM, Barry AP, Chan C, Luftig MA. SoRelle ED, et al. Cell Rep. 2022 Aug 30;40(9):111286. doi: 10.1016/j.celrep.2022.111286. Cell Rep. 2022. PMID: 36044865 Free PMC article. - B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD, Lee HL, Peng CW. Liu CD, et al. J Virol. 2020 Mar 17;94(7):e02028-19. doi: 10.1128/JVI.02028-19. Print 2020 Mar 17. J Virol. 2020. PMID: 31941781 Free PMC article. - The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL, Biel N, Varn M, Patel S, Patel A, Hilding L, Ray A, Ross T, Cramblet WT, Moss CR, Lowrey AJ, Bentz GL. Selby TL, et al. Sci Rep. 2019 Jul 2;9(1):9523. doi: 10.1038/s41598-019-45825-5. Sci Rep. 2019. PMID: 31266997 Free PMC article. - Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.
Shatzer A, Ali MA, Chavez M, Dowdell K, Lee MJ, Tomita Y, El-Hariry I, Trepel JB, Proia DA, Cohen JI. Shatzer A, et al. Leuk Lymphoma. 2017 Apr;58(4):923-931. doi: 10.1080/10428194.2016.1213823. Epub 2016 Aug 11. Leuk Lymphoma. 2017. PMID: 27686857 Free PMC article.
References
- Science. 1967 Sep 1;157(3792):1064-5 - PubMed
- EMBO J. 1987 Jun;6(6):1637-42 - PubMed
- J Gen Virol. 1973 Sep;20(3):391-4 - PubMed
- Int J Cancer. 1973 May;11(3):499-520 - PubMed
- Proc Natl Acad Sci U S A. 1974 Aug;71(8):3283-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials